Ratings by Lake Street (Chad Messer)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/21/2026 | Monopar Therapeutics | MNPR | Maintain | Buy (N/A) |
|
Details | ||
| 4/7/2026 | Oncolytics Biotech | ONCY | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2026 | Immunome Inc. | IMNM | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2025 | Immunome Inc. | IMNM | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2025 | Coya Therapeutics | COYA | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2025 | Genelux Corp. | GNLX | New Coverage | Buy (N/A) |
6.51 (2.89) |
-55.61% | Details | |
| 8/15/2025 | Bolt Biotherapeutics, Inc. | BOLT | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2025 | Oncolytics Biotech | ONCY | New Coverage | Buy (N/A) |
0.86 (0.81) |
-5.81% | Details | |
| 7/9/2025 | Coya Therapeutics | COYA | New Coverage | Buy (N/A) |
6.00 (4.25) |
-29.17% | Details | |
| 5/20/2025 | Bolt Biotherapeutics, Inc. | BOLT | New Coverage | Buy (N/A) |
0.33 (3.83) |
1060.61% | Details | |
| 4/2/2025 | Immunome Inc. | IMNM | New Coverage | Buy (N/A) |
6.26 (22.21) |
254.79% | Details | |
| 4/2/2025 | Lantern Pharma Inc. | LTRN | New Coverage | Buy (N/A) |
3.31 (2.75) |
-16.92% | Details |
